Arteris (NASDAQ:AIP) CEO K Charles Janac Sells 11,452 Shares of Stock

Key Points

• Arteris CEO K. Charles Janac sold 11,452 shares at an average price of $24.27, generating approximately $277,940. After the transaction, he directly owned 154,337 shares, a 6.91% reduction.
• Janac has made several additional sales in recent months, including 100,000 shares on both October 1 and September 1, bringing reported recent sales to a substantial volume.
• Arteris shares were trading near $24.13, well below their 52-week high of $50.26. Despite a recent earnings miss and continuing losses, analysts maintain a “Moderate Buy” consensus with an average price target of $39.43.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) CEO K Janac sold 11,452 shares of the stock in a transaction on Monday, October 5th. The shares were sold at an average price of $24.27, for a total value of $277,940.04. Following the completion of the transaction, the chief executive officer directly owned 154,337 shares of the company's stock, valued at approximately $3,745,758.99. This represents a 6.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

K Charles Janac also recently made the following trade(s):

• On Friday, October 2nd, K Janac sold 9,359 shares of Arteris stock. The stock was sold at an average price of $24.64, for a total transaction of $230,605.76.
• On Thursday, October 1st, K Janac sold 100,000 shares of Arteris stock. The stock was sold at an average price of $23.82, for a total transaction of $2,382,000.00.
• On Tuesday, September 1st, K Janac sold 100,000 shares of Arteris stock. The shares were sold at an average price of $20.75, for a total transaction of $2,075,000.00.
• On Tuesday, August 4th, K Janac sold 26,106 shares of Arteris stock. The stock was sold at an average price of $31.97, for a total transaction of $834,608.82.
• On Monday, August 3rd, K Janac sold 73,894 shares of Arteris stock. The stock was sold at an average price of $30.00, for a total transaction of $2,216,820.00.

Arteris Price Performance

AIP stock traded up $0.16 during mid-day trading on Tuesday, reaching $24.13. The company's stock had a trading volume of 476,272 shares, compared to its average volume of 728,847. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.03. The company's 50 day moving average is $24.73 and its two-hundred day moving average is $28.61. Arteris, Inc. has a fifty-two week low of $12.06 and a fifty-two week high of $50.26. The stock has a market cap of $1.19 billion, a PE ratio of -27.74 and a beta of 1.90.

Arteris (NASDAQ:AIP - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.06). Arteris had a negative return on equity of 295.96% and a negative net margin of 46.70%.The company had revenue of $24.13 million for the quarter, compared to analyst estimates of $23.48 million. Equities research analysts expect that Arteris, Inc. will post -0.68 EPS for the current year.

Key Arteris News

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris won an additional $3.3 million through the Trusted and Assured Microelectronics program to expand its third-party semiconductor IP security-assurance efforts. The company is collaborating with BAE Systems and SiFive, potentially strengthening its position in defense-related and trusted-chip supply chains. Arteris funding announcement
• Neutral Sentiment: CEO K. Charles Janac and Vice President Paul Alpern sold shares, but the filings state the transactions were made to cover tax withholding obligations related to vested equity awards. Because these were tax-related sales rather than clearly discretionary trades, they provide a limited signal about management’s outlook. SEC filing for executive share sales
• Negative Sentiment: Major shareholder Bayview Legacy LLC sold 100,000 shares for approximately $2.38 million, reducing its ownership by 1.22%. The filing did not cite tax withholding as the reason, so the sale could create modest supply pressure and raise concerns about near-term shareholder confidence. SEC filing for Bayview Legacy share sale

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on AIP. Weiss Ratings raised shares of Arteris from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Friday, August 21st. Rosenblatt Securities reaffirmed a "buy" rating and set a $38.00 target price on shares of Arteris in a research note on Friday, August 7th. Oppenheimer began coverage on shares of Arteris in a research note on Thursday, July 16th. They issued an "outperform" rating and a $40.00 price target for the company. Roth Capital began coverage on shares of Arteris in a report on Tuesday, August 4th. They set a "buy" rating and a $40.00 price target for the company. Finally, Craig Hallum began coverage on shares of Arteris in a research report on Monday, September 21st. They set a "buy" rating and a $30.00 price target on the stock. Six equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $39.43.

Institutional Trading of Arteris

Hedge funds and other institutional investors have recently modified their holdings of the business. BlackRock Inc. purchased a new stake in Arteris in the 2nd quarter valued at about $160,129,000. Needham Investment Management LLC increased its position in shares of Arteris by 2.6% during the fourth quarter. Needham Investment Management LLC now owns 3,411,500 shares of the company's stock valued at $52,878,000 after acquiring an additional 86,500 shares during the last quarter. Wellington Management Group LLP raised its stake in shares of Arteris by 0.4% in the 2nd quarter. Wellington Management Group LLP now owns 500,200 shares of the company's stock valued at $24,305,000 after acquiring an additional 1,897 shares during the period. Granahan Investment Management LLC raised its stake in shares of Arteris by 201.0% in the 1st quarter. Granahan Investment Management LLC now owns 713,077 shares of the company's stock valued at $11,723,000 after acquiring an additional 476,181 shares during the period. Finally, Algert Global LLC acquired a new position in shares of Arteris in the 2nd quarter worth approximately $11,602,000. 64.36% of the stock is owned by institutional investors and hedge funds.

Arteris Company Profile

Arteris, Inc is a semiconductor intellectual property (IP) company that develops technologies used in the design of system-on-chip (SoC) devices. Its products help semiconductor and electronics companies connect, manage and protect the various processing, memory and other functional components integrated into complex chips.

The company's portfolio includes network-on-chip (NoC) interconnect IP, which supports communication among different elements within an SoC, as well as cache-coherent interconnect, system IP and related design technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.